changes following chronic cocaine abuse. These studies have examined changes in the nucleus accumbens (NAc) from human overdose victims, as well as non-human primates and rodents (for review, see Hemby (2010) ). From these, a number of important themes have emerged; for example, changes in cellular metabolism, cytoskeletal dynamics, and signal transduction were highly represented. Of particular note, elements of the cAMP, adenylate cyclase, and PKA signaling pathway have been identified by traditional biochemical methods and genomic analyses, as well as proteomic methods (Hemby, 2010) .
For example, ChIP-chip microarray analysis of genes influenced by cocaine exposure has indicated increased histone acetylation at the promoters of the PKA catalytic and RII regulatory subunits, as well as A kinase anchoring protein 9 (AKAP9) (also known as Yotiao) and AKAP8 (AKAP95) (Renthal et al, 2009) . Moreover, increased binding of transcription factor DFosB was identified at the promoters for PKA RIIa, as well as AKAP8 following cocaine vs saline exposure. AKAPs constitute a family of more than 50 proteins across vertebrates and invertebrates, which mediate scaffolding and localization of PKA and other signaling molecules within specific cellular subcompartments (Sanderson and Dell'Acqua, 2011 ).
An isobaric tag for relative and absolute quantitation proteomic analysis of a rat postsynaptic densityenriched subfraction following cocaine self-administration and extinction identified upregulation of AKAP5 (also known as AKAP79/150) (Reissner et al, 2011) . AKAP150 serves to complex PKA and other signaling molecules with ionotropic glutamate receptors (Sanderson and Dell'Acqua, 2011) . Disruption of AKAP scaffolding by microinjection of a cell permeable inhibitor peptide in the NAc (vs control peptide) led to decreased reinstatement of cocaine seeking, indicating a functional role for AKAPs in the neuropathology of drug abuse (Reissner et al, 2011 The repeated identification of the PKA signaling pathway in the cellular adaptations induced by cocaine underscores the importance of this pathway in the addiction process. However, the ubiquitous nature of AKAP and PKA signaling in cellular pathways and subcompartments (eg, synapse vs nucleus, organelles, etc) complicates application of this pathway toward candidate pharmacotherapeutic targets for psychostimulant abuse. In the specific case of AKAP150, however, proteomic and functional studies indicate that synaptic upregulation promotes reinstatement behavior; thus, development of a structurally specific inhibitor targeting this member of the AKAP family may aid inhibition of craving and drug seeking, as a pharmacological adjuvant to cognitive therapy and counseling. (Greenberg et al, 2010) . Moreover, neurosurgical interventions (lesions or deep brain stimulation-DBS) within the ventral internal capsule (VC), ventral striatum (VS), or dACC (treatments for intractable OCD) all act on subcomponents of the vmPFC/OFC/dACC-basal ganglia network (Greenberg et al, 2010) . Indeed, DBS interventions specifically affect vmPFC, OFC, and possibly dACC connections with striatum, thalamus, and/or brainstem (Figure 1 ) (Lehman et al, 2011) . The efficacy of VC/VS DBS (or lesions) for OCD likely requires modulating the OFC/ vmPFC/dACC-basal ganglia circuit. Interestingly, high frequency stimulation (HFS) in a rat homolog of the VC/ VS DBS target reduces OFC activity, enhances local field potential delta band activity in OFC, and enhances synchrony between specific regions within this prefrontal network (McCracken and Grace, 2009 ). Thus, OCD pathophysiology likely represents dysfunctional network interactions rather than only disruption within specific structures.
OCD is often characterized by abnormal risk assessment and unrealistic fears leading to excessive avoidance. Changes in vmPFC/OFC/dACC activity have been linked to fear conditioning and recall in normal subjects (Milad et al, 2007) , with vmPFC activity and structure particularly relevant for fear extinction recall. Overlap ....................................................................................................................................................... ..... in the circuits associated with fear conditioning and OCD dysfunction suggests that these patients may be less flexible in adjusting adverse responses based on new information. Indeed, using a rat model of DBS, with the HFS targeting the VS, a recent study showed that stimulation strengthened fear extinction and retention (RodriguezRomaguera et al, 2012), while enhancing plasticity in the infralimbic, orbitofrontal, and prelimbic cortices (probable homologs of the vmPFC, OFC, and, perhaps, dACC). Taken together, dysfunction of the vmPFC/OFC/dACC network may lead to an increase in incentive-based fear learning and habit formation.
However, PFC regions associated with OCD pathology are not only involved in aversive behaviors and avoidance; they also mediate reward processing. Indeed, OCD patients are also impaired on tasks using rewarding outcomes (Gillan et al, 2011) . They underperform when required to flexibly adjust responses based on new or changing reward feedback. These tendencies suggest impairment in goal-directed behaviors and may lead patients to rely too heavily on habit-based responding, even in the positive-incentive domain (Gillan et al, 2011) . Therefore, rather than being specific to aversive vs reward processing, the vmPFC, OFC, and dACC cortices are involved in value representation, stimulus-outcome associations, and action-outcome associations, regardless of valence. Thus, a heuristic approach could posit that OCD symptoms may not be specific to fear learning and habits, but are related to interference in the normal balance between negative and positive-incentive learning based on values attributed to particular stimuli or actions. Probing potential abnormalities in incentive learning strategies and linking them with functional neurocircuitry can be used both as a research tool and to help design innovative therapeutic approaches.
Brain Serotonin Function in MDMA (Ecstasy) Users: Evidence for Persisting Neurotoxicity 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) is a popular recreational drug, and clinical trials are investigating MDMA as a treatment for anxiety. Animal models suggest that MDMA causes chronic serotonin neurotoxicity, especially in neocortex. Given the role of serotonin in a broad range of brain functions, it is critical to determine whether MDMA is associated with serotonin neurotoxicity in humans. Studies examining the 
